Expertise in
2
conditions

Dr. Doo Cho

Gastroenterology
Office
3020 E Camelback Rd Ste 301, 
Phoenix, AZ 
Expertise in
2
conditions
Office
3020 E Camelback Rd Ste 301, 
Phoenix, AZ 

Overview

Doo Cho is a Gastroenterologist practicing medicine in Phoenix, Arizona.

Dr. Cho is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Esophagitis, Familial Adenomatous Polyposis, Gastroesophageal Reflux Disease (GERD), and Barrett Esophagus.

He is actively involved in clinical research, participating in 8 clinical trials.

Specialties

Gastroenterology

Licenses

Internal Medicine in AZ

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

Office
3020 E Camelback Rd Ste 301, Phoenix, AZ 85016

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

A Phase 3, Multicenter, Randomized, Double-Blind, Parallel-Arm, Placebo-Controlled Maintenance Study of Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 2)
A Phase 3, Multicenter, Randomized, Double-Blind, Parallel-Arm, Placebo-Controlled Maintenance Study of Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 2)
Enrollment Status: Completed
Publish Date: May 13, 2026
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
A Phase 3, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Induction Study of Mirikizumab in Conventional-Failed and Biologic-Failed Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
A Phase 3, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Induction Study of Mirikizumab in Conventional-Failed and Biologic-Failed Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
Enrollment Status: Completed
Publish Date: May 31, 2025
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
A Phase 3 Long-term Safety Extension Study of SHP647 in Subjects With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
A Phase 3 Long-term Safety Extension Study of SHP647 in Subjects With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
Enrollment Status: Completed
Publish Date: June 21, 2024
Intervention Type: Drug
Study Drug: Ontamalimab
Study Phase: Phase 3
A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
Enrollment Status: Completed
Publish Date: October 23, 2023
Intervention Type: Drug
Study Drug: Obeticholic acid
Study Phase: Phase 3
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Crohn's Disease (CARMEN CD 307)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Crohn's Disease (CARMEN CD 307)
Enrollment Status: Terminated
Publish Date: March 31, 2022
Intervention Type: Drug, Other
Study Drug: Ontamalimab
Study Phase: Phase 3
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 303)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 303)
Enrollment Status: Completed
Publish Date: January 14, 2022
Intervention Type: Other, Drug
Study Phase: Phase 3
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Crohn's Disease (CARMEN CD 306)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Crohn's Disease (CARMEN CD 306)
Enrollment Status: Terminated
Publish Date: May 11, 2021
Intervention Type: Other, Biological
Study Phase: Phase 3
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 302)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 302)
Enrollment Status: Terminated
Publish Date: April 26, 2021
Intervention Type: Drug
Study Phase: Phase 3
View 7 Less Clinical Trials
Similar Doctors
Expertise in
10
conditions
Dr. Prasad Iyer
Gastroenterology
Expertise in
10
conditions
Dr. Prasad Iyer
Gastroenterology
Referral may be required

AZ - Cancer GI

5777 E Mayo Blvd, 
Phoenix, AZ 
 (22.4 miles away)
480-933-8137
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Prasad Iyer is a Gastroenterologist practicing medicine in Phoenix, Arizona. Dr. Iyer is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Barrett Esophagus, Esophageal Cancer, Gastroesophageal Reflux Disease (GERD), Endoscopy, and Colonoscopy.

Expertise in
12
conditions
Dr. William Hasler
Gastroenterology
Expertise in
12
conditions
Dr. William Hasler
Gastroenterology
Referral may be required

Mayo Clinic Building Scottsdale

13400 E Shea Blvd, 
Scottsdale, AZ 
 (12.9 miles away)
480-301-8000
Languages Spoken:
English
See accepted insurances
Offers Telehealth

William Hasler is a Gastroenterologist practicing medicine in Scottsdale, Arizona. Dr. Hasler is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Gastroparesis, Gastric Dysmotility, Cannabinoid Hyperemesis Syndrome (CHS), Gastrectomy, and Endoscopy.

Expertise in
12
conditions
Dr. Keith Lindor
Gastroenterology
Expertise in
12
conditions
Dr. Keith Lindor
Gastroenterology
Referral may be required

Mayo Clinic Building Scottsdale

13400 E Shea Blvd, 
Scottsdale, AZ 
 (12.9 miles away)
480-301-8000
Languages Spoken:
English

Keith Lindor is a Gastroenterologist practicing medicine in Scottsdale, Arizona. Dr. Lindor is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Cholangitis, Sclerosing Cholangitis, Primary Biliary Cholangitis, Liver Transplant, and Endoscopy.

Frequently Asked Questions about Dr. Doo Cho

How do I make an appointment with Dr. Doo Cho?

You can book an appointment with Dr. Doo Cho by calling their office at 480-985-1700. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Doo Cho a top-rated expert for Esophagitis?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Doo Cho is classified as an Advanced expert for Esophagitis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Doo Cho specialize in?

While Dr. Doo Cho is a Gastroenterology, they have specific expertise in Esophagitis, Familial Adenomatous Polyposis, and Gastroesophageal Reflux Disease (GERD). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Gastroenterology.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Cho's expertise for a condition
ConditionClose
      View All 24 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile